The Top 100 U.S. In-Vitro Diagnostics Companies

Publisher Name :
Date: 13-Sep-2016
No. of pages: 210

Did you know?


  • Nova Biomedical is the largest privately owned in-vitro diagnostic company in the United States.

  • As of December 31, 2015, Exact Sciences Corporation had 677 full-time employees.

  • Sandy Athenson is Vice President & General Manager, Transfusion Diagnostics at Immucor, Inc..

  • In August, 2016, Alere Inc. received FDA Clearance for its Alere™ i RSV test, the first rapid molecular test that can be used at the point-of-care to detect RSV infection in 13 minutes or less.

  • As of December 31, 2015, more than 19,000 physicians in over 70 countries had ordered OncotypeDX gene expression tests from Genomic Health, Inc. which have been used to guide treatment decisions for more than 600,000 cancer patients worldwide.

  • In January, 2016, Banyan Biomarkers, Inc. and Royal Philips announced that they had entered into a multi-year joint development agreement to develop and commercialise a new handheld blood test to detect and evaluate mild traumatic brain injury at the point-of-care.

  • For the year ended December 31, 2015, Cepheid reported revenue of $538.6 million.


These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 100 U.S. In-Vitro Diagnostics Companies'.

This unique and comprehensive report profiles the top 100 U.S. manufacturers of in-vitro diagnostics. These global leaders are continually developing new and innovative products to add to their already comprehensive portfolios. They are located right across the United States and have highly effective worldwidecommercial networks.

Profile information for each company in ‘The Top 100 U.S. In-Vitro Diagnostics Companies'typically includes:


  • Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses

  • Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers

  • Specialised fields such as Company Description, Ownership, Products, Clinical Specialties/Diseases, Diagnostic Disciplines, Revenue, Year Established and Number of Employees.


Report Target Market:

1) IVD Manufacturers


  • Usage: competitive/financial analysis and strategic partner/alliance identification


2) IVD Suppliers


  • ‘The Top 100 U.S. In-Vitro Diagnostics Companies' is perfect for suppliers of goods and services such as components and sub-assemblies and development, design and manufacturing services who wish to identify top potential customers.


3) IVD Distributors


  • The report is very useful to IVD distributors to identifythe leading U.S. in-vitro diagnostics companies withthe best products.


Note: Most people will be aware of some of the major U.S. in-vitro diagnostics companies such as ACON Laboratories, Inc., Abaxis, Inc., Myriad Genetics, Inc., Ortho Clinical Diagnostics and Quidel Corporationbut this major new report looks at all 100 of the top companies - companies like - GenMark Diagnostics, Inc. - GenMark Diagnostics, Inc. (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The Company's XT-8® system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. As of December 31, 2015, GenMark had an installed base of 633 XT-8® systems, or placements, with their customers. In June, 2016, the Company achieved the CE Mark for its ePlex sample-to-answer multiplex molecular diagnostics System and ePlex Respiratory Pathogen (RP) Panel. GenMark is headquartered in Carlsbad, California, United States, had annual revenue of $39.4 million in 2015 and has 233 employees. The Company is led by Hany Massarany, President And Chief Executive Officer.

Report data field structure is as follows:


  • Company Name

  • Address

  • Telephone

  • Fax

  • Email

  • Website

  • Year Established

  • Number of Employees

  • Key Executives

  • Company Description

  • Products

  • Clinical Specialties/Diseases

  • Diagnostic Disciplines

  • Revenue ($U.S. million)

  • Location Status

  • Ownership

  • Stock Exchange/Ticker Symbol

  • Parent Company

The Top 100 U.S. In-Vitro Diagnostics Companies

Table of Contents

N/A

  • Global In-Vitro Diagnostics (IVD) Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 06-Dec-2016        Price: US 3480 Onwards        Pages: 111
    In-Vitro Diagnostics (IVD) is test that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.Scope of the Report:This report focuses on the In-Vitro Diagnostics (IVD) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applic......
  • Europe Drug of Abuse Testing Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 111
    Notes: Sales, means the sales volume of Drug of Abuse Testing Revenue, means the sales value of Drug of Abuse Testing This report studies sales (consumption) of Drug of Abuse Testing in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Thermo Fisher Scientific - Siemens Medical Solutions......
  • Adenovirus 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 205
    The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices ......
  • Aeromonads 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 200
    The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices ......
  • Campylobacter 2017-2021: Hospitals, Commercial Labs, Physician Offices, Public Health Labs--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 230
    The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices......
  • Chancroid 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 220
    The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices  &......
  • Chlamydia 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 184
    The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices  &......
  • Clostridium 2017-2021: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 225
    The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices&nbs......
  • Cytomegalovirus (CMV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 231
    The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Blood Banks    ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs